Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIV-Reference-Cited by-同舟云学术

Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIV

Published:2020-01-01 Issue:1 Volume:34 Page:103-108
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Courlet Perrine,Stader Felix,Guidi Monia,Alves Saldanha Susana,Stoeckle Marcel,Cavassini Matthias,Battegay Manuel,Buclin Thierry,Decosterd Laurent Arthur,Marzolini Catia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference31 articles.

1. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.;Lancet HIV,2017

2. Future challenges for clinical care of an ageing population infected with HIV: a modelling study;Smit;Lancet Infect Dis,2015

3. Projections of noncommunicable disease and healthcare costs among HIV-positive persons in Italy and the U.S.A.: a modelling study;Smit;PloS One,2017

4. Why the exclusion of older people from clinical research must stop;Watts;BMJ,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Evaluation of Ontogeny Functions of the Major UDP‐Glucuronosyltransferase Enzymes to Underwrite Physiologically Based Pharmacokinetic Modeling in Pediatric Populations;The Journal of Clinical Pharmacology;2024-06-19

2. Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV: A Systematic Review;Clinical Pharmacokinetics;2023-08-10

3. Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 Years;AIDS Research and Human Retroviruses;2023-07-05

4. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults;JAMA;2023-01-03

5. Reversibility of Central Nervous System Adverse Events in Course of Art;Viruses;2022-05-11